EDAP TMS SA (EDAP)
4.60
+0.13
(+2.91%)
USD |
NASDAQ |
Feb 25, 16:00
4.60
0.00 (0.00%)
After-Hours: 16:31
EDAP TMS EPS Diluted (Quarterly) : -0.1565 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Ascendis Pharma A/S | -0.6364 |
| Akari Therapeutics Plc | -0.1948 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.860M |
| Revenue (Quarterly) | 16.22M |
| Total Expenses (Quarterly) | 22.08M |
| Enterprise Value | 163.60M |
| Gross Profit Margin (Quarterly) | 43.02% |
| Profit Margin (Quarterly) | -36.13% |
| Earnings Yield | -12.62% |
| Normalized Earnings Yield | -12.62 |